Researchers at Israel’s Technion Institute have developed a nanomedicine technology for the targeted treatment of gastric tumors. The platform combines anti-cancer and anti-resistance compounds, packaged orally in beta-casein – a constituent of mother’s milk.
http://www.technion.ac.il/en/2016/06/nanomedicine-targets-gastric-tumors/